Sage Therapeutics Inc.
04/19/2024 | Press release | Distributed by Public on 04/19/2024 06:32
Management Change/Compensation - Form 8-K
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 16, 2024, the Board of Directors of Sage Therapeutics, Inc. (the "Company") approved an amendment (the "Plan Amendment") to the Company's Amended and Restated 2016 Inducement Equity Plan (the "2016 Inducement Plan") to (i) decrease the number of shares of common stock of the Company reserved for issuance under the 2016 Inducement Plan to 428,074 shares and (ii) establish that no future awards may be made under the 2016 Inducement Plan after April 16, 2024.
The foregoing description of the Plan Amendment is qualified in its entirety by the full text of the Plan Amendment, a copy of which is attached as Exhibit 10.1 hereto and incorporated by reference herein.